Each MN licensed manufacturer and each MN licensed wholesaler must report to the board every sale, delivery, or other distribution within or into Minnesota of any opiate that is made to any practitioner, pharmacy, hospital, veterinary hospital, or other person who is permitted to possess controlled substances for administration or dispensing to patients.
Each owner of a MN licensed pharmacy with at least one location within Minnesota, must report to the board any intracompany delivery or distribution into MN of any opiate to the extent that those deliveries and distributions are not reported to the board by a licensed wholesaler owned by, under contract to, or otherwise operating on behalf of the owner of the pharmacy.
For purposes of reporting a unit means the individual dosage form of the particular drug product that is prescribed to the patient. One unit equals one tablet, capsule, patch, syringe, milliliter, or gram.
The ARCOS format is being used for reporting with one exception, this is an annual report not a monthly or quarterly report. The following entries in the frequency indicator field will be accepted: M, Q, or Y.
Please ensure you are taking into account the format changes from 2000 to the ARCO’s format (Year 2000 Formatting Changes).
Yes, the ‘zero report’ contains a header record identifying the reporting facility and a single transaction record with a transaction code of ‘7’ (per DEA ARCOS coding) which indicates there were no transactions to report during the previous calendar year.
Reporting for the 2019 calendar year should be based on the Federal controlled substance schedules II-IV and only opiates are to be reported. The Board will be evaluating a potential change to include MN Schedule III’s which are Federally scheduled V’s, for calendar year 2020 reporting and provide information as it becomes available.